On 2025-05-07, IN8bio, Inc. (INAB) announced earnings per share of $-2.10 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.80.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-1.50 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-1.80 | $-2.10 |
| 2025-03-13 | 2024-12-31 | $-2.10 | $-1.20 |
| 2024-11-12 | 2024-09-30 | $-4.20 | $-4.50 |
| 2024-08-08 | 2024-06-30 | $-4.80 | $-5.71 |
| 2024-05-09 | 2024-03-31 | $-5.11 | $-6.01 |
| 2024-03-14 | 2023-12-31 | $-4.80 | $-6.31 |
| 2023-11-09 | 2023-09-30 | $-7.51 | $-6.91 |
| 2023-08-10 | 2023-06-30 | $-8.41 | $-8.11 |
| 2023-05-12 | 2023-03-31 | $-9.91 | $-9.01 |
| 2023-03-30 | 2022-12-31 | $-8.41 | $-9.61 |
| 2022-11-10 | 2022-09-30 | $-8.41 | $-10.21 |
| 2022-08-12 | 2022-06-30 | $-9.91 | $-11.41 |
| 2022-05-12 | 2022-03-31 | $-10.21 | $-9.91 |
| 2022-03-17 | 2021-12-31 | $-6.31 | $-6.31 |
| 2021-11-10 | 2021-09-30 | $-9.91 | $-7.51 |
| 2021-09-10 | 2021-06-30 | $-9.01 | $-30.03 |